Search Results 1311-1320 of 3916 for Solid

  1. A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Exploratory Effectiveness of Nimacimab in Patients With Diabetic Gastroparesis - Mayo Clinic

    Screening or documented historical scintigraphy (within 3 years prior to screening) with approximately 10% or greater of solid contents retained at 4 hours.

  2. Pancreatic neuroendocrine tumors - Symptoms and causes - Mayo Clinic

    Learn about these cancers that start in the hormone-producing cells of the pancreas. Explore innovative treatments, including the Whipple procedure and ...

  3. Chronic Lymphocytic Leukemia Clinical Trials - Mayo Clinic Research

    This phase I trial studies the side effects and best dose of romidepsin in treating patients with lymphoma, chronic lymphocytic leukemia, or solid tumors with ...

  4. Discovery's Edge: Into the Fray - Battling Against MS - Mayo Clinic News Network

    In 2010, they published a groundbreaking study in the New England Journal of Medicine, which offered solid evidence that the cerebral cortex may be the ...

  5. A Study of Binimetinib in Children and Adults With NF1 Plexiform Neurofibromas - Mayo Clinic

    ... solid tumors or neurofibromatosis type I and plexiform neurofibromas. Widemann BC. Brigitte C; Salzer WL. Wanda L; Arceci RJ. Robert J; Blaney SM. Susan M ...

  6. A Study of Ramucirumab Plus Docetaxel in Patients With Urothelial Cancer - Mayo Clinic

    Have measurable disease or nonmeasurable but evaluable disease as defined by Response Evaluation Criteria in Solid Tumors, Version 1.1 (RECIST 1.1). Have an ...

  7. A Study of CIN-107 in Adults With Primary Aldosteronism - Mayo Clinic

    Have had a prior solid organ transplant or cell transplant. 12. Are positive for HIV antibody, hepatitis C virus RNA, or hepatitis B surface antigen. 13 ...

  8. A Study to Evaluate Bardoxolone Methyl in Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD) - Mayo Clinic

    - Kidney or any other solid organ transplant recipient or a planned transplant during the study; - Acute dialysis or acute kidney injury within 12 weeks ...

  9. Videos - Early-Onset Parkinson's Disease and Synucleinopathies - Mayo Clinic Research

    ... solid data. Melani Dizon: Yeah, yeah, yeah. That one. Let's do that one. Dr. Savica: Later-onset, the data that we have, survival. So, in other words, time ...

  10. What is cancer immunotherapy? - Mayo Clinic News Network

    The FDA has approved CAR-T cell therapy to treat several types of blood cancer, and clinical trials are exploring its use for solid tumor cancers. TIL therapy: ...